Skip to content

Advertisement

Open Peer Review Reports for: Central nervous system progression in advanced non–small cell lung cancer patients with EGFR mutations in response to first-line treatment with two EGFR-TKIs, gefitinib and erlotinib: a comparative study

Back to article

Pre-publication versions of this article are available by contacting info@biomedcentral.com.

Original Submission
25 Jan 2016 Submitted Original manuscript
14 May 2016 Reviewed Reviewer Report - Guohui Wan
18 May 2016 Reviewed Reviewer Report - Venkata Parsa
25 Jun 2016 Author responded Author comments - Mengxia Li
Resubmission - Version 2
25 Jun 2016 Submitted Manuscript version 2
8 Nov 2016 Author responded Author comments - Mengxia Li
Resubmission - Version 3
8 Nov 2016 Submitted Manuscript version 3
13 Feb 2017 Author responded Author comments - Mengxia Li
Resubmission - Version 4
13 Feb 2017 Submitted Manuscript version 4
Resubmission - Version 5
Submitted Manuscript version 5
21 Feb 2017 Author responded Author comments - Mengxia Li
Resubmission - Version 6
21 Feb 2017 Submitted Manuscript version 6
Publishing
2 Mar 2017 Editorially accepted
4 Apr 2017 Article published 10.1186/s12885-017-3165-0

How does Open Peer Review work?

Open peer review is a system where authors know who the reviewers are, and the reviewers know who the authors are. If the manuscript is accepted, the named reviewer reports are published alongside the article. Pre-publication versions of the article are available by contacting info@biomedcentral.com.

You can find further information about the peer review system here.

Advertisement